M

Mater Hospital Sydney | Patricia Ritchie Centre for Cancer Care and Research

Research site
(Unclaimed)
Location
25 Rocklands Road, North Sydney, New South Wales, Australia
Site insights

Top conditions

Breast Cancer (3 trials)

Triple Negative Breast Cancer (1 trial)

Top treatments

Palbociclib
Carboplatin
Trilaciclib
Letrozole
Gemcitabine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

1 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) (PRESERVE 2)

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...

Active, not recruiting
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Trilaciclib
Drug: Placebo

Trial sponsors

G

G1 Therapeutics (1 trial)

Pfizer logo

Pfizer (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems